233 related articles for article (PubMed ID: 35148834)
41. Exosomal miR-106b-5p derived from melanoma cell promotes primary melanocytes epithelial-mesenchymal transition through targeting EphA4.
Luan W; Ding Y; Xi H; Ruan H; Lu F; Ma S; Wang J
J Exp Clin Cancer Res; 2021 Mar; 40(1):107. PubMed ID: 33741023
[TBL] [Abstract][Full Text] [Related]
42. Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4.
Royet A; Broutier L; Coissieux MM; Malleval C; Gadot N; Maillet D; Gratadou-Hupon L; Bernet A; Nony P; Treilleux I; Honnorat J; Liebl D; Pelletier L; Berger F; Meyronet D; Castets M; Mehlen P
Oncotarget; 2017 Apr; 8(14):23750-23759. PubMed ID: 28423606
[TBL] [Abstract][Full Text] [Related]
43. Structural and Dynamical Impact of Water Molecules at Substrate- or Product-Binding Sites in Human GMPR Enzyme: A Study by Molecular Dynamics Simulations.
Bairagya HR; Tasneem A; Rai GP; Reyaz S
J Phys Chem B; 2021 Feb; 125(5):1351-1362. PubMed ID: 33369428
[TBL] [Abstract][Full Text] [Related]
44. EphA4 catalytic activity causes inhibition of RhoA GTPase in Xenopus laevis embryos.
Winning RS; Ward EK; Scales JB; Walker GK
Differentiation; 2002 Mar; 70(1):46-55. PubMed ID: 11963655
[TBL] [Abstract][Full Text] [Related]
45. EphA4 receptor is a novel negative regulator of osteoclast activity.
Stiffel V; Amoui M; Sheng MH; Mohan S; Lau KH
J Bone Miner Res; 2014 Apr; 29(4):804-19. PubMed ID: 23983218
[TBL] [Abstract][Full Text] [Related]
46. {alpha}-Syntrophin regulates ARMS localization at the neuromuscular junction and enhances EphA4 signaling in an ARMS-dependent manner.
Luo S; Chen Y; Lai KO; Arévalo JC; Froehner SC; Adams ME; Chao MV; Ip NY
J Cell Biol; 2005 Jun; 169(5):813-24. PubMed ID: 15939763
[TBL] [Abstract][Full Text] [Related]
47. Ectopic EphA4 receptor induces posterior protrusions via FGF signaling in Xenopus embryos.
Park EK; Warner N; Bong YS; Stapleton D; Maeda R; Pawson T; Daar IO
Mol Biol Cell; 2004 Apr; 15(4):1647-55. PubMed ID: 14742708
[TBL] [Abstract][Full Text] [Related]
48. EphrinB3 is an anti-apoptotic ligand that inhibits the dependence receptor functions of EphA4 receptors during adult neurogenesis.
Furne C; Ricard J; Cabrera JR; Pays L; Bethea JR; Mehlen P; Liebl DJ
Biochim Biophys Acta; 2009 Feb; 1793(2):231-8. PubMed ID: 18948148
[TBL] [Abstract][Full Text] [Related]
49. Suppression of phospho-p85α-GTP-Rac1 lipid raft interaction by bichalcone analog attenuates cancer cell invasion.
Lu HL; Chen SS; Hsu WT; Lu YC; Lee CC; Wu TS; Lin ML
Mol Carcinog; 2016 Dec; 55(12):2106-2120. PubMed ID: 26756739
[TBL] [Abstract][Full Text] [Related]
50. Allosteric regulation accompanied by oligomeric state changes of Trypanosoma brucei GMP reductase through cystathionine-β-synthase domain.
Imamura A; Okada T; Mase H; Otani T; Kobayashi T; Tamura M; Kubata BK; Inoue K; Rambo RP; Uchiyama S; Ishii K; Nishimura S; Inui T
Nat Commun; 2020 Apr; 11(1):1837. PubMed ID: 32296055
[TBL] [Abstract][Full Text] [Related]
51. Distinctive binding of three antagonistic peptides to the ephrin-binding pocket of the EphA4 receptor.
Lamberto I; Qin H; Noberini R; Premkumar L; Bourgin C; Riedl SJ; Song J; Pasquale EB
Biochem J; 2012 Jul; 445(1):47-56. PubMed ID: 22489865
[TBL] [Abstract][Full Text] [Related]
52. EPHA4 is overexpressed but not functionally active in Sézary syndrome.
Hameetman L; van der Fits L; Zoutman WH; Out-Luiting JJ; Siegal G; de Esch IJ; Vermeer MH; Tensen CP
Oncotarget; 2015 Oct; 6(31):31868-76. PubMed ID: 26376612
[TBL] [Abstract][Full Text] [Related]
53. A novel miR17/protein tyrosine phosphatase-oc/EphA4 regulatory axis of osteoclast activity.
Lau KW; Sheng MH
Arch Biochem Biophys; 2018 Jul; 650():30-38. PubMed ID: 29763590
[TBL] [Abstract][Full Text] [Related]
54. Regulation of EBV LMP1-triggered EphA4 downregulation in EBV-associated B lymphoma and its impact on patients' survival.
Huang YC; Lin SJ; Lin KM; Chou YC; Lin CW; Yu SC; Chen CL; Shen TL; Chen CK; Lu J; Chen MR; Tsai CH
Blood; 2016 Sep; 128(12):1578-89. PubMed ID: 27338098
[TBL] [Abstract][Full Text] [Related]
55. Transient activation of the MAP kinase signaling pathway by the forward signaling of EphA4 in PC12 cells.
Shin J; Gu C; Kim J; Park S
BMB Rep; 2008 Jun; 41(6):479-84. PubMed ID: 18593533
[TBL] [Abstract][Full Text] [Related]
56. The Rab5 guanylate exchange factor Rin1 regulates endocytosis of the EphA4 receptor in mature excitatory neurons.
Deininger K; Eder M; Kramer ER; Zieglgänsberger W; Dodt HU; Dornmair K; Colicelli J; Klein R
Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12539-44. PubMed ID: 18723684
[TBL] [Abstract][Full Text] [Related]
57. LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding.
Taymans JM; Vancraenenbroeck R; Ollikainen P; Beilina A; Lobbestael E; De Maeyer M; Baekelandt V; Cookson MR
PLoS One; 2011; 6(8):e23207. PubMed ID: 21858031
[TBL] [Abstract][Full Text] [Related]
58. Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion.
Saintigny P; Peng S; Zhang L; Sen B; Wistuba II; Lippman SM; Girard L; Minna JD; Heymach JV; Johnson FM
Mol Cancer Ther; 2012 Sep; 11(9):2021-32. PubMed ID: 22807579
[TBL] [Abstract][Full Text] [Related]
59. Desipramine targets astrocytes to attenuate synaptic plasticity via modulation of the ephrinA3/EphA4 signalling.
Tanasic S; Mattusch C; Wagner EM; Eder M; Rupprecht R; Rammes G; Di Benedetto B
Neuropharmacology; 2016 Jun; 105():154-163. PubMed ID: 26785076
[TBL] [Abstract][Full Text] [Related]
60. New biochemical insights into the dynamics of water molecules at the GMP or IMP binding site of human GMPR enzyme: A molecular dynamics study.
Bairagya HR; Tasneem A; Rai GP; Reyaz S
Proteins; 2022 Jan; 90(1):200-217. PubMed ID: 34368983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
